Posted On: 03/25/2014 9:52:16 AM
Post# of 94312
$GILD Recent News
Nasdaq slumps 1.2%, but Dow dips just 0.2%: Stock market live blog recap 3:39 p.m. March 24, 2014 - blogs.marketwatch.com
Biotech has a second straight sell-off; sector mutual funds take it on chin 10:40 a.m. March 24, 2014 - blogs.marketwatch.com
Biotech's Friday selloff: Are sector bears growling or just stretching? 5:08 p.m. March 21, 2014 - blogs.marketwatch.com
Newscast: Stocks close lower after late fade 4:26 p.m. March 21, 2014 - MarketWatch
First Solar extends winning streak; Symantec plunges 3:06 p.m. March 21, 2014 - Ben Eisen
Picking stocks to weather any market 1:15 p.m. March 21, 2014 - Mark Hulbert
The Nasdaq has a message to deliver 1:56 p.m. March 20, 2014 - The Trading Deck
Aeropostale slides; Liberty Media drops Sirius plan 4:15 p.m. March 14, 2014 - Saumya Vaishampayan
S&P 500 marks 50th record close; Nasdaq slips as biotechs reverse: Stock market live blog (recap) 4:38 p.m. March 6, 2014 - blogs.marketwatch.com
Winning approval for new drugs may get harder, analyst warns 3:56 p.m. Feb. 28, 2014 - blogs.marketwatch.com
Best stocks for legalized marijuana 1:37 p.m. Feb. 27, 2014 - blogs.marketwatch.com
When it comes to stocks, play follow the leader 3:54 p.m. Feb. 13, 2014 - The Trading Deck
3D Systems down on weak outlook, CVS quits cigarettes 4:16 p.m. Feb. 5, 2014 - Saumya Vaishampayan
Time Warner, Twitter, Walt Disney are stocks to watch 5:48 a.m. Feb. 5, 2014 - Sue Chang
Tableau Software, Myriad shares rally after earnings 6:02 p.m. Feb. 4, 2014 - Wallace Witkowski
Gilead does the expected by beating earnings and sales forecasts 5:13 p.m. Feb. 4, 2014 - blogs.marketwatch.com
Updates, advisories and surprises 4:31 p.m. Feb. 4, 2014 - MarketWatch
Gilead beats sales, earnings forecasts 4:27 p.m. Feb. 4, 2014 - Russ Britt
Gilead sales forecast beats $10.93B analyst view 4:18 p.m. Feb. 4, 2014 - Russ Britt
Gilead forecasts 2014 sales of $11.3B to $11.5B 4:17 p.m. Feb. 4, 2014 - Russ Britt
Biotech Sell-Off Brings Value To U.S. Healthcare Stocks 8:08 a.m. Today - Seeking Alpha
'Mad Money' Lightning Round: Stay Far Away From Boardwalk Partners 6:00 a.m. Today - TheStreet.com
Stick to Buying on Weakness Unless This Happens 9:58 p.m. March 24, 2014 - InvestorPlace.com
Jim Cramer's 'Mad Money' Recap: The Enemy Is Us 8:14 p.m. March 24, 2014 - TheStreet.com
Trading Winds Blow Cold for Some Hot Stocks 7:17 p.m. March 24, 2014 - The Wall Street Journal Interactive Edition
U.S. Stocks Decline 7:03 p.m. March 24, 2014 - The Wall Street Journal Interactive Edition
Top Industry Groups Take Big Hits In Market Sell-Off 4:56 p.m. March 24, 2014 - Investors Business Daily
Gilead Down on Sovaldi Price Issue - Analyst Blog 4:45 p.m. March 24, 2014 - Zacks.com
Are Biotech Stocks Oversold? - Analyst Blog 4:26 p.m. March 24, 2014 - Zacks.com
Don't Hate Josh Brown For Calling Biotech a Bubble. Learn From Him. 4:17 p.m. March 24, 2014 - TheStreet.com
Dow Drops as Manufacturing Sector Shows Weakness, Nasdaq Slides as Biotechs Decline 4:14 p.m. March 24, 2014 - TheStreet.com
GILD, BIB, Others: How Worried Are Market-Makers About 'Government Pricing?' 3:14 p.m. March 24, 2014 - Seeking Alpha
3 ETFs Tumble Most on Biotech Sell-off - ETF News And Commentary 2:00 p.m. March 24, 2014 - Zacks.com
A Bubble Burst? Momentum Names Are Falling Hard 1:48 p.m. March 24, 2014 - Seeking Alpha
Sovaldi's Patent War 1:04 p.m. March 24, 2014 - Seeking Alpha
Breakthrough Therapy Status for Pfizer's Drug - Analyst Blog 11:30 a.m. March 24, 2014 - Zacks.com
Another Bad Day in Biotech Stocks, Pace of Selling Accelerates 11:21 a.m. March 24, 2014 - TheStreet.com
Weekly Insider Sells Highlight: KERX, ORCL, QCOM, GILD 11:06 a.m. March 24, 2014 - GuruFocus.com
Why Gilead Sciences (GILD) Shares Are Lower Today 10:55 a.m. March 24, 2014 - TheStreet.com
Weekly CFO Sells Highlight: Google Inc., Facebook Inc., Gilead Sciences Inc. ... 10:54 a.m. March 24, 2014 - GuruFocus.com
Janssen to Present New Simeprevir Data at The International Liver Congress™ 2014 of the European Association for the Study of the Liver (EASL) 8:00 a.m. March 24, 2014 - PR Newswire - PRF
Idenix Pharmaceuticals Intends to Appeal Norway District Court Decision Regarding Patent Invalidity Case 7:01 a.m. March 24, 2014 - GlobeNewswire
Gilead Sciences Prices Hepatitis C Drug at $84,000; Versartis Commences Trading on the NASDAQ 12:30 a.m. March 24, 2014 - ACCESSWIRE
AHF: Gilead’s ‘Obscene’ $180M Payday for CEO Fuels Shareholder Resolution on Compensation 4:57 p.m. March 17, 2014 - BusinessWire - BZX
Idenix Pharmaceuticals Files Patent Infringement Lawsuits Against Gilead Sciences in Europe 7:03 a.m. March 14, 2014 - GlobeNewswire
Idenix Pharmaceuticals Files Patent Infringement Lawsuits Against Gilead Sciences in Europe 7:01 a.m. March 14, 2014 - Thomson Reuters ONE
Investor-Edge.com Most Active Equities Watch List: Staples, Gilead Sciences, Office Depot, and Sprint 8:00 a.m. March 7, 2014 - PR Newswire - PRF
Patient Support Programs, Financial Results, and Stock Price Movements - Analyst Notes on Gilead, Forest Laboratories, Thermo Fisher Scientific, HCA Holdings, and Nektar 8:25 a.m. March 6, 2014 - PR Newswire - PRF
Critical Alerts For Baidu.com, Gilead Sciences, Deere, Alexion Pharmaceuticals, and Ford Released By InvestorsObserver 9:31 a.m. March 5, 2014 - PR Newswire - PRF
Gilead Prices $4 Billion of Senior Unsecured Notes 6:15 p.m. March 4, 2014 - BusinessWire - BZX
Insider Trading Profile Alerts for Cisco, Gilead Sciences, Exxon Mobil, Facebook, Microsoft, and Bank of America 8:30 a.m. March 3, 2014 - PR Newswire - PRF
Gilead Sciences to Present at the 34th Cowen & Co. Healthcare Conference on Monday, March 3 5:00 p.m. Feb. 28, 2014 - BusinessWire - BZX
Aethlon Medical Expands Clinical Network Through DaVita Agreement 3:01 p.m. Feb. 26, 2014 - ACCESSWIRE
Gilead Sciences to Present at the RBC Capital Markets 2014 Global Healthcare Conference on Wednesday, February 26 5:00 p.m. Feb. 25, 2014 - BusinessWire - BZX
Insider Trading Update for Gilead Sciences, eBay, Walt Disney, Hewlett-Packard, Newmont Mining, and Apple 8:30 a.m. Feb. 24, 2014 - PR Newswire - PRF
CURx Pharmaceuticals Announces License Agreement with Gilead Sciences 8:00 a.m. Feb. 19, 2014 - PR Newswire - PRF
Galectin Therapeutics Leaps Ahead with SBH Sciences Partnership 11:02 a.m. Feb. 13, 2014 - ACCESSWIRE
Brazilian Pharmaceutical Market 2014-2024 10:03 a.m. Feb. 12, 2014 - PR Newswire - PRF
Gilead Sciences to Present at Two Upcoming Investor Conferences 5:00 p.m. Feb. 10, 2014 - BusinessWire - BZX
Gilead Files for U.S. Approval of Ledipasvir/Sofosbuvir Fixed-Dose Combination Tablet for Genotype 1 Hepatitis C 4:05 p.m. Feb. 10, 2014 - BusinessWire - BZX
Nasdaq slumps 1.2%, but Dow dips just 0.2%: Stock market live blog recap 3:39 p.m. March 24, 2014 - blogs.marketwatch.com
Biotech has a second straight sell-off; sector mutual funds take it on chin 10:40 a.m. March 24, 2014 - blogs.marketwatch.com
Biotech's Friday selloff: Are sector bears growling or just stretching? 5:08 p.m. March 21, 2014 - blogs.marketwatch.com
Newscast: Stocks close lower after late fade 4:26 p.m. March 21, 2014 - MarketWatch
First Solar extends winning streak; Symantec plunges 3:06 p.m. March 21, 2014 - Ben Eisen
Picking stocks to weather any market 1:15 p.m. March 21, 2014 - Mark Hulbert
The Nasdaq has a message to deliver 1:56 p.m. March 20, 2014 - The Trading Deck
Aeropostale slides; Liberty Media drops Sirius plan 4:15 p.m. March 14, 2014 - Saumya Vaishampayan
S&P 500 marks 50th record close; Nasdaq slips as biotechs reverse: Stock market live blog (recap) 4:38 p.m. March 6, 2014 - blogs.marketwatch.com
Winning approval for new drugs may get harder, analyst warns 3:56 p.m. Feb. 28, 2014 - blogs.marketwatch.com
Best stocks for legalized marijuana 1:37 p.m. Feb. 27, 2014 - blogs.marketwatch.com
When it comes to stocks, play follow the leader 3:54 p.m. Feb. 13, 2014 - The Trading Deck
3D Systems down on weak outlook, CVS quits cigarettes 4:16 p.m. Feb. 5, 2014 - Saumya Vaishampayan
Time Warner, Twitter, Walt Disney are stocks to watch 5:48 a.m. Feb. 5, 2014 - Sue Chang
Tableau Software, Myriad shares rally after earnings 6:02 p.m. Feb. 4, 2014 - Wallace Witkowski
Gilead does the expected by beating earnings and sales forecasts 5:13 p.m. Feb. 4, 2014 - blogs.marketwatch.com
Updates, advisories and surprises 4:31 p.m. Feb. 4, 2014 - MarketWatch
Gilead beats sales, earnings forecasts 4:27 p.m. Feb. 4, 2014 - Russ Britt
Gilead sales forecast beats $10.93B analyst view 4:18 p.m. Feb. 4, 2014 - Russ Britt
Gilead forecasts 2014 sales of $11.3B to $11.5B 4:17 p.m. Feb. 4, 2014 - Russ Britt
Biotech Sell-Off Brings Value To U.S. Healthcare Stocks 8:08 a.m. Today - Seeking Alpha
'Mad Money' Lightning Round: Stay Far Away From Boardwalk Partners 6:00 a.m. Today - TheStreet.com
Stick to Buying on Weakness Unless This Happens 9:58 p.m. March 24, 2014 - InvestorPlace.com
Jim Cramer's 'Mad Money' Recap: The Enemy Is Us 8:14 p.m. March 24, 2014 - TheStreet.com
Trading Winds Blow Cold for Some Hot Stocks 7:17 p.m. March 24, 2014 - The Wall Street Journal Interactive Edition
U.S. Stocks Decline 7:03 p.m. March 24, 2014 - The Wall Street Journal Interactive Edition
Top Industry Groups Take Big Hits In Market Sell-Off 4:56 p.m. March 24, 2014 - Investors Business Daily
Gilead Down on Sovaldi Price Issue - Analyst Blog 4:45 p.m. March 24, 2014 - Zacks.com
Are Biotech Stocks Oversold? - Analyst Blog 4:26 p.m. March 24, 2014 - Zacks.com
Don't Hate Josh Brown For Calling Biotech a Bubble. Learn From Him. 4:17 p.m. March 24, 2014 - TheStreet.com
Dow Drops as Manufacturing Sector Shows Weakness, Nasdaq Slides as Biotechs Decline 4:14 p.m. March 24, 2014 - TheStreet.com
GILD, BIB, Others: How Worried Are Market-Makers About 'Government Pricing?' 3:14 p.m. March 24, 2014 - Seeking Alpha
3 ETFs Tumble Most on Biotech Sell-off - ETF News And Commentary 2:00 p.m. March 24, 2014 - Zacks.com
A Bubble Burst? Momentum Names Are Falling Hard 1:48 p.m. March 24, 2014 - Seeking Alpha
Sovaldi's Patent War 1:04 p.m. March 24, 2014 - Seeking Alpha
Breakthrough Therapy Status for Pfizer's Drug - Analyst Blog 11:30 a.m. March 24, 2014 - Zacks.com
Another Bad Day in Biotech Stocks, Pace of Selling Accelerates 11:21 a.m. March 24, 2014 - TheStreet.com
Weekly Insider Sells Highlight: KERX, ORCL, QCOM, GILD 11:06 a.m. March 24, 2014 - GuruFocus.com
Why Gilead Sciences (GILD) Shares Are Lower Today 10:55 a.m. March 24, 2014 - TheStreet.com
Weekly CFO Sells Highlight: Google Inc., Facebook Inc., Gilead Sciences Inc. ... 10:54 a.m. March 24, 2014 - GuruFocus.com
Janssen to Present New Simeprevir Data at The International Liver Congress™ 2014 of the European Association for the Study of the Liver (EASL) 8:00 a.m. March 24, 2014 - PR Newswire - PRF
Idenix Pharmaceuticals Intends to Appeal Norway District Court Decision Regarding Patent Invalidity Case 7:01 a.m. March 24, 2014 - GlobeNewswire
Gilead Sciences Prices Hepatitis C Drug at $84,000; Versartis Commences Trading on the NASDAQ 12:30 a.m. March 24, 2014 - ACCESSWIRE
AHF: Gilead’s ‘Obscene’ $180M Payday for CEO Fuels Shareholder Resolution on Compensation 4:57 p.m. March 17, 2014 - BusinessWire - BZX
Idenix Pharmaceuticals Files Patent Infringement Lawsuits Against Gilead Sciences in Europe 7:03 a.m. March 14, 2014 - GlobeNewswire
Idenix Pharmaceuticals Files Patent Infringement Lawsuits Against Gilead Sciences in Europe 7:01 a.m. March 14, 2014 - Thomson Reuters ONE
Investor-Edge.com Most Active Equities Watch List: Staples, Gilead Sciences, Office Depot, and Sprint 8:00 a.m. March 7, 2014 - PR Newswire - PRF
Patient Support Programs, Financial Results, and Stock Price Movements - Analyst Notes on Gilead, Forest Laboratories, Thermo Fisher Scientific, HCA Holdings, and Nektar 8:25 a.m. March 6, 2014 - PR Newswire - PRF
Critical Alerts For Baidu.com, Gilead Sciences, Deere, Alexion Pharmaceuticals, and Ford Released By InvestorsObserver 9:31 a.m. March 5, 2014 - PR Newswire - PRF
Gilead Prices $4 Billion of Senior Unsecured Notes 6:15 p.m. March 4, 2014 - BusinessWire - BZX
Insider Trading Profile Alerts for Cisco, Gilead Sciences, Exxon Mobil, Facebook, Microsoft, and Bank of America 8:30 a.m. March 3, 2014 - PR Newswire - PRF
Gilead Sciences to Present at the 34th Cowen & Co. Healthcare Conference on Monday, March 3 5:00 p.m. Feb. 28, 2014 - BusinessWire - BZX
Aethlon Medical Expands Clinical Network Through DaVita Agreement 3:01 p.m. Feb. 26, 2014 - ACCESSWIRE
Gilead Sciences to Present at the RBC Capital Markets 2014 Global Healthcare Conference on Wednesday, February 26 5:00 p.m. Feb. 25, 2014 - BusinessWire - BZX
Insider Trading Update for Gilead Sciences, eBay, Walt Disney, Hewlett-Packard, Newmont Mining, and Apple 8:30 a.m. Feb. 24, 2014 - PR Newswire - PRF
CURx Pharmaceuticals Announces License Agreement with Gilead Sciences 8:00 a.m. Feb. 19, 2014 - PR Newswire - PRF
Galectin Therapeutics Leaps Ahead with SBH Sciences Partnership 11:02 a.m. Feb. 13, 2014 - ACCESSWIRE
Brazilian Pharmaceutical Market 2014-2024 10:03 a.m. Feb. 12, 2014 - PR Newswire - PRF
Gilead Sciences to Present at Two Upcoming Investor Conferences 5:00 p.m. Feb. 10, 2014 - BusinessWire - BZX
Gilead Files for U.S. Approval of Ledipasvir/Sofosbuvir Fixed-Dose Combination Tablet for Genotype 1 Hepatitis C 4:05 p.m. Feb. 10, 2014 - BusinessWire - BZX
(0)
(0)
